MED8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.339600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.725600E-01
Normal-vs-Stage2
5.751400E-01
Normal-vs-Stage3
9.791400E-01
Normal-vs-Stage4
1.009570E-01
Stage1-vs-Stage2
3.284400E-01
Stage1-vs-Stage3
9.266400E-01
Stage1-vs-Stage4
1.212990E-01
Stage2-vs-Stage3
4.974800E-01
Stage2-vs-Stage4
5.103200E-01
Stage3-vs-Stage4
3.391200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.744800E-01
Normal-vs-AfricanAmerican
2.619800E-01
Normal-vs-Asian
3.834600E-01
Caucasian-vs-AfricanAmerican
5.884200E-01
Caucasian-vs-Asian
4.683000E-01
AfricanAmerican-vs-Asian
9.967400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.026400E-01
Normal-vs-Female
5.600000E-01
Male-vs-Female
4.278200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.523600E-01
Normal-vs-Age(41-60Yrs)
3.272400E-01
Normal-vs-Age(61-80Yrs)
7.674800E-01
Normal-vs-Age(81-100Yrs)
9.880800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.419400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.317800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.975000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.494400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.595800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.754000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.877800E-01
Normal-vs-Daily Drinker
8.370400E-01
Normal-vs-Weekly Drinker
5.706800E-01
Normal-vs-Occasional Drinker
4.593600E-01
Normal-vs-Social Drinker
3.937200E-01
Non Drinker-vs-Daily Drinker
4.639800E-01
Non Drinker-vs-Weekly Drinker
1.903830E-01
Non Drinker-vs-Occasional Drinker
9.299600E-02
Non Drinker-vs-Social Drinker
1.227230E-01
Daily Drinker-vs-Weekly Drinker
3.630800E-01
Daily Drinker-vs-Occasional Drinker
3.642000E-01
Daily Drinker-vs-Social Drinker
4.317000E-01
Weekly Drinker-vs-Occasional Drinker
6.993000E-01
Weekly Drinker-vs-Social Drinker
6.318000E-01
Occasional Drinker-vs-Social Drinker
8.800600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.680400E-01
Normal-vs-Grade 2
8.417000E-01
Normal-vs-Grade 3
8.139000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.355900E-02
Grade 1-vs-Grade 3
2.737400E-01
Grade 1-vs-Grade 4
7.680400E-01
Grade 2-vs-Grade 3
2.295000E-01
Grade 2-vs-Grade 4
8.417000E-01
Grade 3-vs-Grade 4
8.139000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.982400E-01
Normal-vs-NonDiabetic
6.622200E-01
Diabetic-vs-NonDiabetic
3.141400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.079800E-01
Normal-vs-NoPancreatitis
7.523600E-01
Pancreatitis-vs-NoPancreatitis
6.957700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.487000E-01
Normal-vs-N1
6.189600E-01
N0-vs-N1
9.962400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.827200E-01
Normal-vs-TP53-NonMutant
9.559200E-01
TP53-Mutant-vs-TP53-NonMutant
5.140100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
